Novavax, Inc. (NASDAQ:NVAX)

CAPS Rating: 1 out of 5

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.

Recs

0
Player Avatar pchop123 (76.53) Submitted: 7/11/2012 10:56:11 AM : Underperform Start Price: $1.94 NVAX Score: -8.45

take recent gains off the table

Featured Broker Partners


Advertisement